Gilead Sciences Inc., GILD is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Gilead Sciences Inc., GILD has a market cap of 118873.07. Since its IPO date on the 1/22/1992, Gilead Sciences Inc., GILD performance year to date is -11.57%. Today Gilead Sciences Inc., GILD has gained -8.98%, with a current price of 80.6.
Ownership of the company is 0.50% for insider ownership while institutional ownership is 81.90%. The management of the company have seen the company have a payout ratio of 14.30%. Return of assets are at 36.60%, with return on investment at 45.90%.
In terms of debt levels and profit levels, Gilead Sciences Inc., GILD is seeing a long-term debt/equity of 1.57. While Total debt/equity is 1.7. With a profit margin of 52.80%, this is combined with a gross margin of 86.90%, and operating margin of 65.40%. Gilead Sciences Inc. ability to meet debt levels, with a current ratio of 1.8, while the quick ratio is 1.6.
For the last year Gilead Sciences Inc., GILD has seen a EPS growth of 62.00%. A performance for the year of -20.04%. The 52-week high is -31.78%, and the 52-week low is 3.44%. The average volume for Gilead Sciences Inc., GILD is 31745867.
With a target price of 110.37, can Gilead Sciences Inc., GILD reach this target? Looking at the value indicators of Gilead Sciences Inc., GILD. Gilead Sciences Inc. has a P/E of 7.58 and a forward P/E of 7.2. Perhaps the more useful indicator than P/E, is PEG which has a value of 9.65. Gilead Sciences Inc. also has a P/S and a P/B of 3.62 and 9.14 respectively. For P/cash, Gilead Sciences Inc. has a value of 14.29, while it is 7.47 for P/free cash flow.
At the current price of 80.6, Gilead Sciences Inc. has a dividend yield of 2.12%. We see a return on equity of 105.70%.
Looking more long-term Gilead Sciences Inc., is projected to get an EPS growth for the next five years of 0.79%. In the short-term an EPS growth of 2.29% in the next year is forecasted. This is after a EPS growth of 62.00% for this year and for the last five years a 48.30% growth has been seen.